G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,804 | -14.0% | 20,697 | +48.6% | 0.00% | – |
| Q2 2023 | $34,673 | +0.2% | 13,925 | +7.8% | 0.00% | – |
| Q1 2023 | $34,612 | -42.7% | 12,915 | +16.1% | 0.00% | – |
| Q4 2022 | $60,409 | -95.7% | 11,125 | -90.2% | 0.00% | – |
| Q3 2022 | $1,412,000 | +1057.4% | 113,061 | +601.9% | 0.00% | – |
| Q1 2022 | $122,000 | -51.6% | 16,108 | -34.7% | 0.00% | – |
| Q4 2021 | $252,000 | -30.4% | 24,669 | -8.4% | 0.00% | – |
| Q3 2021 | $362,000 | -31.8% | 26,930 | +11.2% | 0.00% | – |
| Q2 2021 | $531,000 | +20.4% | 24,214 | +32.3% | 0.00% | – |
| Q1 2021 | $441,000 | -96.4% | 18,307 | -97.3% | 0.00% | -100.0% |
| Q4 2020 | $12,152,000 | +221.1% | 675,480 | +106.2% | 0.00% | +300.0% |
| Q3 2020 | $3,784,000 | -35.8% | 327,584 | +34.9% | 0.00% | -50.0% |
| Q2 2020 | $5,893,000 | +98.4% | 242,906 | -9.9% | 0.00% | +100.0% |
| Q1 2020 | $2,971,000 | -51.6% | 269,582 | +16.0% | 0.00% | -50.0% |
| Q4 2019 | $6,142,000 | +9.1% | 232,412 | -6.0% | 0.00% | +100.0% |
| Q3 2019 | $5,632,000 | +365.8% | 247,212 | +527.1% | 0.00% | – |
| Q2 2019 | $1,209,000 | +3.4% | 39,422 | -44.0% | 0.00% | – |
| Q1 2019 | $1,169,000 | +84.4% | 70,423 | +112.7% | 0.00% | – |
| Q4 2018 | $634,000 | -91.3% | 33,116 | -76.1% | 0.00% | -100.0% |
| Q3 2018 | $7,248,000 | +240.6% | 138,605 | +183.0% | 0.00% | +100.0% |
| Q2 2018 | $2,128,000 | – | 48,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
| EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
| Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
| Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
| Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
| Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
| BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |